Condensed Consolidated Statements of Operations - USD ($) |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Income Statement [Abstract] | ||||
| Revenue | $ 1,975,439 | $ 1,932,352 | $ 7,673,532 | $ 15,242,560 |
| Operating Expenses | ||||
| Compensation and employee benefits | 1,660,658 | 1,372,481 | 6,266,317 | 7,783,331 |
| General and administrative expenses | 1,068,400 | 990,826 | 3,294,275 | 4,018,094 |
| Professional services | 1,145,809 | 1,499,534 | 3,328,222 | 2,518,394 |
| Rent expense | 51,432 | 61,006 | ||
| Lease expense | 232,773 | 258,477 | ||
| Amortization of contract asset | 129,072 | 129,072 | ||
| Credit benefit | (316,576) | (177,917) | (1,393,131) | |
| Impairment of goodwill | 6,058,000 | |||
| Impairment of long-lived intangible assets | 3,090,881 | |||
| Total operating expenses | 3,738,795 | 3,923,847 | 13,072,742 | 22,334,046 |
| Operating loss | (1,763,356) | (1,991,495) | (5,399,210) | (7,091,486) |
| Other income (expenses) | ||||
| Interest expense | (4,580) | (112,786) | (492,643) | (533,390) |
| Change in fair value of warrant liabilities | 16,599 | 1,116,082 | 1,320,871 | 2,803,638 |
| Gain on extinguishment of forward purchase derivative | 3,336,213 | |||
| Costs incurred to secure financing | (987,621) | |||
| Discount on common stock sold pursuant to the ELOC | (76,553) | |||
| Change in the fair value of deferred consideration | 161,000 | 79,475 | 361,449 | |
| Loss on ELOC share settlements | (27,880) | |||
| Total other income (expenses) | (15,861) | 1,164,296 | 3,179,742 | 2,631,697 |
| Net loss | (1,779,217) | (827,199) | (2,219,468) | (4,459,789) |
| Provision (benefit) for income taxes | (58,470) | 43,859,686 | ||
| Net loss | (1,779,217) | (827,199) | (2,160,998) | (48,319,475) |
| Deemed dividend on Series B Preferred Stock redemption | (87,612) | (241,435) | ||
| Net loss attributable to common stockholders | $ (1,866,829) | $ (827,199) | $ (2,402,433) | $ (48,319,475) |
| Weighted average shares outstanding, basic | 4,353,099 | 2,786,538 | 2,921,648 | 2,772,867 |
| Weighted average shares outstanding, diluted | 4,353,099 | 2,786,538 | 2,921,648 | 2,772,867 |
| Basic net loss per share | $ (0.43) | $ (0.30) | $ (0.82) | $ (17.43) |
| Diluted net loss per share | $ (0.43) | $ (0.30) | $ (0.82) | $ (17.43) |
| X | ||||||||||
- Definition Change in fair value of deferred consideration. No definition available.
|
| X | ||||||||||
- Definition Costs incurred to secure equity line of credit. No definition available.
|
| X | ||||||||||
- Definition Discount on common stock sold pursuant to eloc. No definition available.
|
| X | ||||||||||
- Definition Loss on ELOC share settlements. No definition available.
|
| X | ||||||||||
- Definition Rent expense. No definition available.
|
| X | ||||||||||
- Definition Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for employee benefit and equity-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss for finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of operating lease expense. Excludes sublease income. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense (reversal of expense) for expected credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|